Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2015-05-11

FDA Approved: BETAXOLOL HYDROCHLORIDE — Supplemental Application (Sandoz Inc)

View source ↗

Summary

The FDA approved a supplemental application for betaxolol hydrochloride from Sandoz Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Betaxolol hydrochloride (betaxolol hydrochloride)

Snippet

SUPPL AP for BETAXOLOL HYDROCHLORIDE (BETAXOLOL HYDROCHLORIDE)